Interpretable Chirality-Aware Graph Neural Network for Quantitative Structure Activity Relationship Modeling in Drug Discovery

Authors

  • Yunchao (Lance) Liu Vanderbilt University
  • Yu Wang Vanderbilt University
  • Oanh Vu Vanderbilt University
  • Rocco Moretti Vanderbilt University
  • Bobby Bodenheimer Vanderbilt University
  • Jens Meiler Vanderbilt University Leipzig University
  • Tyler Derr Vanderbilt University

DOI:

https://doi.org/10.1609/aaai.v37i12.26679

Keywords:

General

Abstract

In computer-aided drug discovery, quantitative structure activity relation models are trained to predict biological activity from chemical structure. Despite the recent success of applying graph neural network to this task, important chemical information such as molecular chirality is ignored. To fill this crucial gap, we propose Molecular-Kernel Graph NeuralNetwork (MolKGNN) for molecular representation learning, which features SE(3)-/conformation invariance, chirality-awareness, and interpretability. For our MolKGNN, we first design a molecular graph convolution to capture the chemical pattern by comparing the atom's similarity with the learnable molecular kernels. Furthermore, we propagate the similarity score to capture the higher-order chemical pattern. To assess the method, we conduct a comprehensive evaluation with nine well-curated datasets spanning numerous important drug targets that feature realistic high class imbalance and it demonstrates the superiority of MolKGNN over other graph neural networks in computer-aided drug discovery. Meanwhile, the learned kernels identify patterns that agree with domain knowledge, confirming the pragmatic interpretability of this approach. Our code and supplementary material are publicly available at https://github.com/meilerlab/MolKGNN.

Downloads

Published

2023-06-26

How to Cite

Liu, Y. (Lance), Wang, Y., Vu, O., Moretti, R., Bodenheimer, B., Meiler, J., & Derr, T. (2023). Interpretable Chirality-Aware Graph Neural Network for Quantitative Structure Activity Relationship Modeling in Drug Discovery. Proceedings of the AAAI Conference on Artificial Intelligence, 37(12), 14356-14364. https://doi.org/10.1609/aaai.v37i12.26679

Issue

Section

AAAI Special Track on AI for Social Impact